The abstract indicates that the Anavex molecules "increased complex I activity, in a Ca2+-dependent and s1R antagonist-sensitive manner." donepezil is left off that list. So that indicates some differential effects between SR1 agonists.
IF the entire article is available somewhere not behind a paywall, I'd like to read the details.
Market Data 
Markets 
AI
